Dave Muoio

Opt-in "Exposure Notifications" are included in new operating system updates on both companies' platforms and available now to worldwide public health agencies.

The young service says that it has been seeing a marked increase in users over the past few months.

Alongside the purchase and service launch, the digital health company also shared news of a $57 million investment from Perceptive Advisors.

The consumer-facing digital platform for health testing was forced to pump the brakes on a similar offering roughly two months ago.

Also: Intel, UPenn and others employ AI for brain tumor identification; DrChrono integrates EHRsynergy's documentation tool.

AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.

A bipartisan quartet of lawmakers wrote to Congressional leaders on the need to deliver additional funds through the longstanding Rural Health Care Program.

Following a virtual consultation, both companies are supplying Rutgers Clinical Genomics Laboratory's saliva-based molecular test to consumers at $150 per kit.

Downloaded and used by millions of U.K. and U.S. residents, the study app provided data on which symptoms are associated with confirmed cases, and roughly how many untested users likely have the disease.

Lucid Lane combines regular virtual coaching with mobile, data-driven care plans.